ストックスクリーナーアプリを入手
0.5006
7.84%
-0.0426
プレマーケット:
.47
-0.0306
-6.11%
Renovaro Inc (RENB) 最新ニュース
Predictive Oncology pushing forward with Renovaro merger despite $10.8M loss in 2024 - The Business Journals
Predictive Oncology Advances AI Merger Plans Despite $10.8M Loss: Key Strategic Moves Revealed - Stock Titan
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewswire
Predictive Oncology Reports Year-End 2024 Financial Results and Provides Corporate Update - GlobeNewswire Inc.
Bank of New York Mellon Corp Grows Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World
PawTides.com Partners with Rescue 22 Foundation to Support Veterans and Rescue Dogs - openPR
Rhumbline Advisers Acquires 62,204 Shares of Renovaro Inc. (NASDAQ:RENB) - Defense World
New York State Common Retirement Fund Trims Stake in Renovaro Inc. (NASDAQ:RENB) - Defense World
Predictive Oncology receives financing from Renovaro Biosciences - Pennsylvania Business Report -
Renovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments? - Yahoo Finance
Sea (SE) Reports Q4: Everything You Need To Know Ahead Of Earnings - The Globe and Mail
Renovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreement - The Business Journals
MarketsMedicine Hat News - Financial Content
Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB) - The Globe and Mail
What To Expect From Best Buy’s (BBY) Q4 Earnings - The Globe and Mail
Milestone Merger Payment made with Predictive Oncology - openPR
Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive Oncology - Marketscreener.com
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewswire
Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro Biosciences - Marketscreener.com
Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences - The Manila Times
Renovaro Biosciences Advances Financing for AI-Driven Integration and Strategic Expansion in Oncology through Acquisition of Predictive Oncology - Nasdaq
Can Renovaro's AI Oncology Merger Unlock Value From 150,000+ Tumor Samples? - StockTitan
Can This AI-Powered Oncology Merger Transform Cancer Treatment? First Financing Milestone Reached - StockTitan
Renovaro Stock Price, Quotes and Forecasts | NASDAQ:RENB - Benzinga
Renovaro Biosciences Announces Merger with BioSymetrics - TipRanks
Rocket Lab Stock Is Down 30% in the Last Month. Should You Buy the Dip or Run Far Away? - The Globe and Mail
Renovaro announces $15 million in equity - MSN
Renovaro Inc. (RENB) Merges with BioSymetrics to Advance AI-Driven Cancer Research - Insider Monkey
Renovaro Announces $15 million in Equity Committed - GlobeNewswire
Renovaro secures $15 million for cancer AI technology By Investing.com - Investing.com Australia
Enochian Biosciences Stock: AI-Powered Merger Fuels Growth - sharewise
Sector Update: Health Care -February 26, 2025 at 03:37 pm EST - Marketscreener.com
Merger Agreement with BioSymetrics to Accelerate Biomarker Identification, Enhance Drug Discovery and Expand Precision Medicine Applications in Advanced Cancer Diagnosis and Treatment | FinancialContent Business Page - FinancialContent
Renovaro and BioSymetrics merge to boost AI-driven drug discovery - Investing.com
Renovaro and BioSymetrics merge to boost AI-driven drug discovery By Investing.com - Investing.com South Africa
$15 Million in New Equity to Support Advanced Cancer Diagnostics, Personalized Immunotherapy, Treatments & Drug Discovery: Renovaro Stock Symbol: RENB - WICZ
Renovaro Agrees to Merge With BioSymetrics -February 26, 2025 at 01:47 pm EST - Marketscreener.com
Renovaro & Biosymetrics Announce Definitive Merger Agreement -February 26, 2025 at 01:27 pm EST - Marketscreener.com
Renovaro and BioSymetrics Announce Definitive Merger - GlobeNewswire
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and - EIN News
Renovaro Gets $15 Million in Equity Committed; Shares Rise -February 26, 2025 at 10:58 am EST - Marketscreener.com
Renovaro secures $15 million for cancer AI technology - Investing.com
Renovaro Inc. Secures $15 Million in Additional Equity to Advance Cancer Diagnostics and Therapeutics - Nasdaq
Can $15M in Fresh Funding Help Renovaro Transform Cancer Treatment with AI? - StockTitan
Merger Agreement with BioSymetrics to Accelerate Biomarker Identification, Enhance Drug Discovery and Expand Precision Medicine Applications in Advanced Cancer Diagnosis and Treatment - The Globe and Mail
Renovaro (NASDAQ:RENB) Posts Earnings Results - MarketBeat
Investors Eye Biotech Sector as Cancer Therapy Market Surges - KamloopsBCNow
Renovaro: Fiscal Q2 Earnings Snapshot - CTPost
Renovaro: Fiscal Q2 Earnings Snapshot -February 19, 2025 at 05:03 pm EST - Marketscreener.com
3.89%
0.13%
大文字化:
|
ボリューム (24 時間):